99-6529. Agency Information Collection Activities; Announcement of OMB Approval; New Animal Drugs for Investigational Use  

  • [Federal Register Volume 64, Number 52 (Thursday, March 18, 1999)]
    [Notices]
    [Page 13430]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-6529]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    [Docket No. 98N-0363]
    
    
    Agency Information Collection Activities; Announcement of OMB 
    Approval; New Animal Drugs for Investigational Use
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
    collection of information entitled ``New Animal Drugs for 
    Investigational Use'' has been approved by the Office of Management and 
    Budget (OMB) under the Paperwork Reduction Act of 1995.
    
    FOR FURTHER INFORMATION CONTACT: Denver Presley, Office of Information 
    Resources Management (HFA-250), Food and Drug Administration, 5600 
    Fishers Lane, Rockville, MD 20857, 301-827-1472.
    
    SUPPLEMENTARY INFORMATION: In the Federal Register of December 2, 1998 
    (63 FR 66548), the agency announced that the proposed information 
    collection had been submitted to OMB for review and clearance under 44 
    U.S.C. 3507. An agency may not conduct or sponsor, and a person is not 
    required to respond to, a collection of information unless it displays 
    a currently valid OMB control number. OMB has now approved the 
    information collection and has assigned OMB control number 0910-0117. 
    The approval expires on January 31, 2002. A copy of the supporting 
    statement for this information collection is available on the Internet 
    at ``http://www.fda.gov/ohrms/dockets''.
    
        Dated: March 11, 1999.
     William K. Hubbard,
     Acting Deputy Commissioner for Policy.
    [FR Doc. 99-6529 Filed 3-17-99; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
03/18/1999
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
99-6529
Pages:
13430-13430 (1 pages)
Docket Numbers:
Docket No. 98N-0363
PDF File:
99-6529.pdf